EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Current Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹160 Cr | ₹138 Cr | ₹113 Cr | ₹77 Cr | ₹74 Cr |
What is the latest Total Current Liabilities ratio of EVEREST ORGANICS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹160 Cr |
Mar2023 | ₹138 Cr |
Mar2022 | ₹113 Cr |
Mar2021 | ₹77 Cr |
Mar2020 | ₹74 Cr |
How is Total Current Liabilities of EVEREST ORGANICS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹160 Cr | 16.37 | |
Mar2023 | ₹138 Cr | 22.23 | |
Mar2022 | ₹113 Cr | 45.50 | |
Mar2021 | ₹77 Cr | 4.53 | |
Mar2020 | ₹74 Cr | - |
Compare Total Current Liabilities of peers of EVEREST ORGANICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
EVEREST ORGANICS | ₹375.1 Cr | -6.7% | 16.8% | 184.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹375,100.0 Cr | -5.6% | -9.9% | -12.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,698.0 Cr | -2.5% | -8.4% | 21.7% | Stock Analytics | |
CIPLA | ₹128,239.0 Cr | -0.8% | 1.8% | -1.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,216.0 Cr | -2.4% | -4% | 4.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,855.0 Cr | -0.3% | -0.9% | -9.7% | Stock Analytics |
EVEREST ORGANICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
EVEREST ORGANICS | -6.7% |
16.8% |
184.1% |
SENSEX | -1.2% |
-1.2% |
-1.7% |
You may also like the below Video Courses